UMIN-CTR Clinical Trial

Basic information
Public title	Prospective study of pain biomarkers
Acronym	Pain biomarkers
Scientific Title	Prospcetive clinical study for exploring pain biomarkers
Scientific Title:Acronym	Clinical study of pain biomarkers
Region	Japan

Condition
Condition	pain conditions
Classification by specialty	Neurology Orthopedics Anesthesiology Rehabilitation medicine
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	exploring pain biomarkers
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	pain biomarkers
Key secondary outcomes

Base
Study type	Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	18 years-old <=
Age-upper limit	100 years-old >
Gender	Male and Female
Key inclusion criteria	with any pain conditions
Key exclusion criteria	who can not be assessed on pain
Target sample size	2000

Research contact person
Name of lead principal investigator	1st name Masahiko Middle name Last name Sumitani
Organization	The University of Tokyo
Division name	Hospital
Zip code	113-0033
Address	Hongo 7-3-1, Bunkyo, Tokyo, Japan
TEL	03-3815-5411
Email	sumitanim-ane@h.u-tokyo.ac.jp

Public contact
Name of contact person	1st name Masahiko Middle name Last name Sumitani
Organization	The University of Tokyo
Division name	Hospital
Zip code	113-0033
Address	Hongo 7-3-1, Bunkyo, Tokyo, Japan
TEL	03-3815-5411
Homepage URL
Email	sumitanim-ane@h.u-tokyo.ac.jp

Sponsor
Institute	The University of Tokyo
Institute
Department

Funding Source
Organization	The University of Tokyo
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization	Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	The University of Tokyo
Address	Hongo 7-3-1, Bunkyo, Tokyo, Japan
Tel	03-3815-5411
Email	sumitanim-ane@h.u-tokyo.ac.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2022 Year 07 Month 27 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Enrolling by invitation
Date of protocol fixation	2022 Year 05 Month 29 Day
Date of IRB	2022 Year 05 Month 29 Day
Anticipated trial start date	2022 Year 05 Month 29 Day
Last follow-up date	2032 Year 05 Month 28 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information	observational study

Management information
Registered date	2022 Year 07 Month 27 Day
Last modified on	2022 Year 07 Month 27 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055253